
Valencell
Bringing wearables to market with today's most accurate biometrics.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
$10.5m | Series E | ||
Total Funding | 000k |
Related Content
Valencell specializes in developing highly accurate photoplethysmography (PPG) sensors for wearable technology. These sensors continuously measure heart rate and other biometrics, providing valuable health insights. The company serves both consumer and medical markets, offering solutions that enhance the functionality of wearables and hearables. Valencell's business model revolves around licensing its sensor technology to device manufacturers, thereby generating revenue through licensing fees and royalties. The company operates in the health and wellness sector, focusing on innovations like cuffless blood pressure monitoring. By partnering with various organizations, Valencell aims to enable biometric use cases that improve people's lives.
Keywords: PPG sensors, wearables, biometrics, heart rate monitoring, health insights, licensing, hearables, cuffless BP monitoring, wellness, medical devices.